The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria

Clinical Microbiology Reviews
Xian-Zhi LiH Nikaido

Abstract

The global emergence of multidrug-resistant Gram-negative bacteria is a growing threat to antibiotic therapy. The chromosomally encoded drug efflux mechanisms that are ubiquitous in these bacteria greatly contribute to antibiotic resistance and present a major challenge for antibiotic development. Multidrug pumps, particularly those represented by the clinically relevant AcrAB-TolC and Mex pumps of the resistance-nodulation-division (RND) superfamily, not only mediate intrinsic and acquired multidrug resistance (MDR) but also are involved in other functions, including the bacterial stress response and pathogenicity. Additionally, efflux pumps interact synergistically with other resistance mechanisms (e.g., with the outer membrane permeability barrier) to increase resistance levels. Since the discovery of RND pumps in the early 1990s, remarkable scientific and technological advances have allowed for an in-depth understanding of the structural and biochemical basis, substrate profiles, molecular regulation, and inhibition of MDR pumps. However, the development of clinically useful efflux pump inhibitors and/or new antibiotics that can bypass pump effects continues to be a challenge. Plasmid-borne efflux pump genes (including thos...Continue Reading

References

Jan 1, 1978·Annual Review of Microbiology·J Davies, D I Smith
Mar 1, 1992·The Journal of Antimicrobial Chemotherapy·G AubertG Dorche
Jan 1, 1992·European Biophysics Journal : EBJ·O MoranM C Sorgato
Sep 1, 1992·Microbiological Reviews·M Vaara
Oct 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·O Lomovskaya, K Lewis
Sep 1, 1992·Antimicrobial Agents and Chemotherapy·N Masuda, S Ohya
Apr 1, 1992·Antimicrobial Agents and Chemotherapy·S B Levy
Apr 1, 1992·Journal of General Microbiology·S PaulJ Das
May 1, 1992·Molecular Microbiology·P Plésiat, H Nikaido
May 1, 1991·The Journal of Antimicrobial Chemotherapy·J A RegueraJ L Martínez
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A A NeyfakhL B Chen
Jul 1, 1991·The Journal of Antimicrobial Chemotherapy·K Sato, T Nakae
May 1, 1991·Antimicrobial Agents and Chemotherapy·D M Livermore, K W Davy
Sep 1, 1990·Antimicrobial Agents and Chemotherapy·H FukudaS Iyobe
Aug 1, 1990·FEMS Microbiology Letters·K Brzostek, W W Nichols
Mar 1, 1990·FEMS Microbiology Letters·A S PurewalM Midgley
May 1, 1987·Journal of General Microbiology·J L Burns, A L Smith
Jan 1, 1985·Antimicrobial Agents and Chemotherapy·F Yoshimura, H Nikaido
Nov 1, 1989·Antimicrobial Agents and Chemotherapy·H Nikaido
Jan 1, 1983·Journal of Bacteriology·H NikaidoJ Foulds
Apr 1, 1984·Infection and Immunity·J T DouglasA J Winter
Jan 1, 1984·The Journal of Antimicrobial Chemotherapy·L Gutmann, Y A Chabbert

❮ Previous
Next ❯

Citations

Feb 13, 2016·Nature Communications·Laetitia DauryOlivier Lambert
Jan 29, 2016·Journal of Medicinal Chemistry·Jordan D GoodreidRobert A Batey
Jan 21, 2016·Proceedings of the National Academy of Sciences of the United States of America·Alfred D KinanaHiroshi Nikaido
Oct 16, 2015·Journal of Pharmacological and Toxicological Methods·Donald L MelchiorShimon Schuldiner
Oct 12, 2015·Computational Biology and Chemistry·Mariya A ToropovaAndrey A Toropov
Mar 1, 2016·ACS Infectious Diseases·Helen I ZgurskayaS Gnanakaran
Jul 21, 2015·Annals of the New York Academy of Sciences·David C Hooper, George A Jacoby
Mar 16, 2016·Proceedings of the National Academy of Sciences of the United States of America·Hanno SjutsTimothy J Opperman
Sep 4, 2015·Nature Reviews. Urology·Hosam M ZowawiDavid L Paterson
Apr 20, 2016·Frontiers in Microbiology·Guyue ChengZonghui Yuan
Jun 11, 2015·Microbial Biotechnology·Carlos Molina-SantiagoJuan-Luis Ramos
Aug 26, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Antonio OliverCarlos Juan
Jun 27, 2015·Frontiers in Microbiology·João AnesMarta Martins
May 3, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Ling-Fu HuangChin-Lu Chang
Jun 1, 2016·Frontiers in Microbiology·Boris ShaskolskiyDmitry Gryadunov
May 21, 2016·Future Microbiology·Theodoros KarampatakisEmmanuel Roilides
Oct 19, 2016·Current Opinion in Microbiology·Zachary Aron, Timothy J Opperman
Jul 30, 2015·PloS One·Shankar ThangamaniMohamed N Seleem
Jan 26, 2016·Biotechnology and Bioengineering·Congqiang ZhangHeng-Phon Too
Sep 14, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Sara Hernando-AmadoJosé L Martínez
Oct 22, 2016·Trends in Microbiology·Gerard D Wright
Aug 16, 2016·International Journal of Antimicrobial Agents·Sophie BaronAbiola Olumuyiwa Olaitan
Sep 16, 2016·BMC Microbiology·Hafiz Ghulam Murtaza SaleemEric Charles Reynolds
Oct 7, 2016·Frontiers in Microbiology·Manuel Alcalde-RicoJosé L Martínez
Oct 11, 2016·Applied Biochemistry and Biotechnology·Krupa M ParmarNishant A Dafale
Oct 22, 2016·Annals of the New York Academy of Sciences·Michael R GillingsSasha G Tetu
Oct 30, 2016·Biochemical and Biophysical Research Communications·Alfred D KinanaHiroshi Nikaido

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

ABC Transporters & Multidrug Resistance

ABC Transporters or ATP-Binding Cassette Transporters are responsible for pumping out antibiotics in the cell and can lead to multidrug resistance in bacteria. Discover the latest research on ABC Transporters & Multidrug Resistance here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Advanced Drug Delivery Reviews
Ayush Kumar, Herbert P Schweizer
Recent Patents on Anti-infective Drug Discovery
Barbara Zechini, Ilaria Versace
© 2021 Meta ULC. All rights reserved